Eliquis (apixaban tablets) Patient Assistance Program

Don’t let the high cost of brand factor Xa inhibitor anticoagulant disrupt your stroke prevention or VTE care. We help eligible patients access Eliquis (apixaban tablets) for as little as $69.95 per month through the manufacturer’s Patient Assistance Program.

HIPAA Compliant

BBB Accredited

Secure Website

Key ​Takeaways:

What Is Eliquis Prescription Assistance Program?

The Eliquis Patient Assistance Program is a manufacturer-sponsored initiative that helps eligible patients access Eliquis (used to reduce stroke and systemic embolism risk in atrial fibrillation, prevent and treat DVT and PE, and prevent recurrent thromboembolism) at little or no cost when they meet specific income, insurance, and clinical criteria. The program is free to apply for, but the enrollment process involves detailed applications, cardiology or primary care coordination, supporting documentation, and ongoing renewal — which can be overwhelming when you are managing atrial fibrillation or recovering from a venous thromboembolism.

At AffordMyPrescriptions, our Patient Advocates handle the entire Eliquis PAP enrollment for a flat $69.95 per month. We complete the application, coordinate with your prescriber for required medical documentation, follow up with the manufacturer’s program until approval, manage your refills, and handle annual re-certification — so you never face a gap in your Eliquis anticoagulation therapy.

AffordMyPrescriptions eliminates that burden. For a flat $69.95 per month, our Patient Advocates handle every step of your Eliquis enrollment — from the initial application through ongoing refills and annual re-enrollment — so you never face a gap in your anticoagulation treatment.

Pharmacy Price Comparison

PharmacyPrice (30-DayYou Save W/ Us
Walgreens~$720/moSave ~$650/mo
CVS Pharmacy~$750/moSave ~$680/mo
Walmart~$580/moSave ~$510/mo
Costco~$550/moSave ~$480/mo
Medicare negotiated (2026)~$295/moSave under IRA negotiation

Our Pricing:

$69.95 Per month

1 Medications

$79.95 Per Month

2 Medications

$89.95 Per Month

3 Medications

$99.95 Per Month

4+ Medications

How Much Does Eliquis Cost — and How to Get It Free or Low-Cost

Many people search for Eliquis cost without insurancefree Eliquis, or how to afford Eliquis. Here’s the reality: Eliquis has a list price of about $346 per month, and without insurance retail prices typically run $520 to $800 per month depending on the pharmacy and dose. The Bristol Myers Squibb Patient Assistance Foundation can provide brand-name Eliquis at no medication cost to qualifying uninsured patients who meet income requirements. There is no ongoing “free trial,” but for those who qualify, this program is the closest path to free Eliquis. We manage the entire application for a flat $69.95/month service fee.

Can Medicare Patients Get Eliquis Assistance?

Yes. Medicare patients cannot use the Eliquis $10 Co-pay Card or any manufacturer coupon — that’s federal law. But Medicare Part D patients may qualify for the Bristol Myers Squibb Patient Assistance Foundation based on income, typically at or below ~300% of the federal poverty level, reviewed case-by-case. If you’re on Medicare and struggling with Eliquis’s cost, we can check your eligibility and handle the application.

Why choose us For Your Eliquis Prescription Program?

Staying on a blood thinner consistently is critical to preventing strokes and clots. We remove the administrative burden so you can focus on your health.

Enroll

Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.

We Advocate

Our specialists help gather documentation, complete applications, and coordinate with program providers.

Receive Medication

Once approved, you may receive your medication through the assistance program while we help manage ongoing paperwork and renewals.

Eliquis Coupons, Copay Cards & Savings Cards vs. Patient Assistance Programs

If you’re searching for an Eliquis manufacturer couponcopay card, or savings card, here’s the honest breakdown. Bristol Myers Squibb and Pfizer offer the Eliquis $10 Co-pay Card, which can bring your cost down to as little as $10 for a 30-day or first 90-day supply (then about $30 for later 90-day refills) — but only if you have commercial (private) insurance that covers Eliquis. It is not valid for anyone on Medicare, Medicaid, TRICARE, or other government programs. The card caps at a $2,000 annual benefit. If you’re uninsured, on Medicare, or the copay card doesn’t apply to you, that’s exactly where our Patient Assistance Program helps.

Limitations of Coupons

  • Prices fluctuate — savings aren’t guaranteed month-to-month
  • Copay accumulators may prevent savings from counting toward deductible
  • Cards expire and require constant renewal
  • Subject to strict monthly or annual maximum savings caps
  • Can’t be used with Medicare, Medicaid, or government insurance

Advantages of PAP Through Us

  • Fixed $69.95/month — never changes regardless of retail price
  • No expiration — continuous access as long as you qualify
  • Medication supplied directly from the manufacturer
  • We manage all paperwork, refills, and renewals
  • If denied, we explore alternative savings on your behalf

if you have commercial insurance, the Eliquis $10 Co-pay Card is your cheapest option. If you’re on Medicare, uninsured, or the copay card doesn’t cover your situation, our Patient Assistance Program gets you brand-name Eliquis for a flat $69.95/month, no insurance required

DO YOU QUALIFY?

Eligibility is generally determined by annual household income and insurance status. Most programs follow guidelines that include limits of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because requirements vary by program and household, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation and determine if you qualify for Eliquis assistance.

What Is Eliquis & How Does It Work?

Eliquis is a direct oral anticoagulant (DOAC) that directly inhibits activated factor X (Xa) in the coagulation cascade. Designed for predictable pharmacokinetics, no routine lab monitoring, and substantially fewer drug-food interactions than warfarin. Among the most prescribed anticoagulants globally for atrial fibrillation stroke prevention and VTE management.

How it works:

Atrial fibrillation increases stroke risk via thromboembolism from the left atrium. Deep vein thrombosis and pulmonary embolism arise from venous stasis, endothelial injury, or hypercoagulable states. Both conditions require anticoagulation to prevent catastrophic clotting events.

Apixaban directly inhibits factor Xa — blocking conversion of prothrombin to thrombin and downstream clot formation. Direct factor Xa inhibition is more targeted than warfarin’s broader vitamin K-dependent factor effects. Twice-daily oral dosing produces predictable steady-state anticoagulation without need for routine INR monitoring. Andexanet alfa (Andexxa) is the specific reversal agent for life-threatening bleeding.

Form and use:

Eliquis 2.5 mg or 5 mg tablets twice daily. Atrial fibrillation: 5 mg twice daily (or 2.5 mg twice daily if ≥2 of: age ≥80, weight ≤60 kg, serum creatinine ≥1.5 mg/dL). DVT/PE treatment: 10 mg twice daily for 7 days, then 5 mg twice daily. Extended VTE prevention: 2.5 mg twice daily. Take with or without food. Hold before procedures per surgical risk; bridging strategy guided by cardiology and surgery.

Generic availability:

No US generic Eliquis yet (patent litigation ongoing — generic anticipated in coming years). Other DOACs (all brand): rivaroxaban (Xarelto — once-daily, broader VTE-specific dosing), dabigatran (Pradaxa — direct thrombin inhibitor, twice-daily, requires renal dosing), edoxaban (Savaysa — once-daily). Generic warfarin (Coumadin generic) very cheap and effective for most indications but requires INR monitoring (target 2.0–3.0 typical, 2.5–3.5 for mechanical mitral valve), dietary vitamin K consistency, and management of many drug-drug interactions. Specific reversal agents: andexanet alfa (Andexxa) for apixaban and rivaroxaban; idarucizumab (Praxbind) for dabigatran; prothrombin complex concentrate for warfarin urgent reversal. For mechanical heart valves, warfarin remains standard (DOACs contraindicated).

Warnings:

**Boxed warning: increased risk of thrombotic events (including stroke) if anticoagulation is interrupted; epidural or spinal hematomas in patients receiving neuraxial anesthesia or undergoing spinal puncture.** Bleeding (major — life-threatening; GI, intracranial, retroperitoneal possible), drug interactions (strong dual CYP3A4 and P-gp inhibitors increase apixaban levels — caution with ketoconazole, itraconazole, ritonavir, clarithromycin; strong inducers decrease — caution with rifampin, phenytoin, carbamazepine, St. John’s wort), renal and hepatic impairment dose adjustments, mechanical heart valves contraindicated, antiphospholipid syndrome with triple positivity (DOAC not preferred), pregnancy (limited data — generally avoided; warfarin or LMWH preferred per trimester). Patients undergoing surgery or invasive procedures require periprocedural management.

FAQ (Frequently Asked Questions)

How much does Eliquis cost without insurance?

Brand Eliquis $550–$750 per month. Under the IRA Medicare drug price negotiation effective 2026, the negotiated maximum fair price is approximately $295 per month for Medicare beneficiaries. Generic warfarin (alternative anticoagulant) costs about $5 per month but requires INR monitoring.

Both anticoagulants prevent stroke in atrial fibrillation and treat VTE. Warfarin is a vitamin K antagonist — requires INR monitoring, has many dietary and drug interactions, and is very inexpensive. Eliquis directly inhibits factor Xa — predictable dosing without routine monitoring, fewer interactions, slightly lower major bleeding (especially intracranial) in trials, but substantially more expensive without insurance or assistance.

All DOACs prevent stroke in AFib and treat VTE. Eliquis (apixaban) and Savaysa (edoxaban) are factor Xa inhibitors; Pradaxa (dabigatran) is a direct thrombin inhibitor; Xarelto (rivaroxaban) is also a factor Xa inhibitor. Trial data show Eliquis with slightly lower major bleeding and similar efficacy vs warfarin. Choice often by twice-daily (Eliquis, Pradaxa) vs once-daily (Xarelto, Savaysa), renal function, insurance coverage, and patient preference.

No routine INR or PT monitoring required — major advantage over warfarin. Periodic checks of renal function (creatinine clearance affects dosing) and CBC for hemoglobin/platelets recommended. No dietary vitamin K restrictions.

No — DOACs are contraindicated for mechanical heart valves. Warfarin remains standard for mechanical valve thromboprophylaxis. Bioprosthetic valves are different and may allow DOAC use per cardiology guidance.

Andexanet alfa (Andexxa) is the specific reversal agent for life-threatening bleeding on Eliquis or Xarelto. Available in most emergency departments. Idarucizumab (Praxbind) reverses Pradaxa. Hold Eliquis, control bleeding source, supportive care, and reversal as needed.

We help explore generic warfarin (very cheap, effective for many patients with INR monitoring), Xarelto/Pradaxa/Savaysa copay programs (alternative DOACs), Medicare Part D Extra Help and state SPAP, IRA negotiated Medicare pricing (effective 2026), manufacturer copay programs for commercial insurance, and foundation aid (Patient Access Network, Patient Advocate Foundation, NeedyMeds, GoodRx).

Take Control of Your Medication Costs

Stroke and clot prevention should not be skipped over cost — anticoagulation interruption carries serious risk. Multiple effective options exist including very inexpensive generic warfarin. Our Eliquis advocacy team is ready to verify your eligibility, complete the manufacturer application on your behalf, and manage your prescription through approval, delivery, and renewal — for a flat $69.95 per month. If we cannot help you access Eliquis through a Patient Assistance Program, you are not charged. Call (833) 556-2729 or check your eligibility online today.

Submit Enrollment Form

Start free by filling out a simple online form.

Receive Welcome Call

Our specialist will contact you for a quick welcome call.

We Manage The Process

Our team handles everything, so you can focus on your health.

Receive Welcome Call

We Manage The Process